TVM Capital Life Science at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

TVM Capital Life Science takes part in 1 session at BIO-Europe 2026 in Cologne. Its program centres on late-stage investment in biotech, within the Business of Biotech track. TVM Capital Life Science, which sponsors the meeting, joins BNP Paribas Asset Management, Jeito Capital and Forbion to look at how late-stage funding helps companies scale.

OrganizationBIO-Europe 2026 Attendance
◇Silver Sponsor
tvm-capital.com
Investors & financeSilver sponsor
Life science venture firm investing in early-stage therapeutics and commercial-stage medtech, diagnostics and late-stage therapeutics.
Panel
Tue Nov 10
15:00–15:45
Scaling Success: The Dynamics of Late-Stage Investment in Biotech
How investors back biotechs whose products are close to market, from regulatory hurdles and scaling up to going public or being acquired.
with BNP Paribas Asset Management, Jeito Capital, Forbion

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from TVM Capital Life Science

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction